Otitis Media

Published on 21/03/2015 by admin

Filed under Pediatrics

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1718 times

Chapter 59 Otitis Media

PATHOPHYSIOLOGY

Acute otitis media (AOM) is an inflammation of the middle ear. Children 6 years of age and younger are at particular risk for acute otitis media because their eustachian tubes are shorter and more horizontal, and lack the cartilaginous support found in older children and adults. This allows the eustachian tubes to collapse, which causes negative pressure in the middle ear. In turn, there is impaired drainage of middle ear fluid and possible reflux of pharyngeal secretions into this normally sterile area. The eustachian tubes of infants and children with cleft palate or Down syndrome are also wider, so they remain open; this allows bacteria to travel easily from the nasopharynx into the middle ear, and this further predisposes such children to infection. Acute otitis media is the most common infection for which antibacterial agents are prescribed for children in the United States. Among childhood diseases, it is second in prevalence only to the common cold, accounting for 1 in 3 pediatric sick visits in this country and over 13 million annual prescriptions. Growing concerns about the rising rates of antibacterial resistance have prompted changes in the medical management of uncomplicated AOM. Two types of otitis media are common in clinical pediatrics: acute otitis media and otitis media with effusion.

MEDICAL MANAGEMENT

Because of concerns about drug resistance, observation without use of antibacterial agents in a child with uncomplicated AOM is an option for selected children based on diagnostic certainty, age, illness severity, and assurance of follow-up. This option refers to deferring antibacterial treatment for 48 to 72 hours and limiting management to symptom relief; it is limited to otherwise healthy children 6 months to 2 years of age with nonsevere illness and to older children without severe symptoms. Children less than 6 months of age should be treated with antibacterial therapy regardless of diagnostic certainty.

If the decision is made to treat with an antibacterial agent, the first-line antibiotic medication most often prescribed is amoxicillin, 80-90 mg/kg per day, for 10 days. Clinical response should occur within 48 to 72 hours. The second-line medication regimen (to be used when an amoxicillin-resistant organism is suspected) includes amoxicillin with clavulanate (Augmentin, a second-generation cephalosporin), cefaclor, or co-trimoxazole. In the penicillin-allergic child, azithromycin may be used.

Recurrent otitis media may be treated by myringotomy, a surgical procedure in which pressure-equalizing (PE) tubes are inserted into the tympanic membrane (refer to the Medical Management section in this chapter). This allows ventilation of the middle ear, relieves the negative pressure, and permits drainage of fluid. The tubes usually fall out after 6 to 12 months. Complications that may result include atrophy of the tympanic membrane, tympanosclerosis (scarring of the tympanic membrane), chronic perforation, and cholesteatoma.

Initial management of the child involves observation or treatment with antibiotic therapy (optional at this time). In most cases, otitis media with effusion resolves spontaneously within 3 months. Parents should be encouraged to avoid exposing their children to passive smoking as a means of controlling an environmental risk factor. Myringotomy is not recommended for initial management of otitis media with effusion in an otherwise healthy child.

After 3 months, if the child has hearing in the normal range, as indicated by a hearing threshold level of better than 20 dB in the better-hearing ear, the child is observed or treated with antibiotics (this remains optional at this time). In most cases, otitis media with effusion resolves spontaneously.

If the child has bilateral hearing deficits of 20 dB hearing threshold level or worse, the child is treated with antibiotic therapy or undergoes a bilateral myringotomy with tympanostomy tubes. Either one or both treatment approaches may be chosen to manage bilateral otitis media with effusion that has lasted a total of 3 months in an otherwise healthy child aged 1 to 3 years who has a bilateral hearing deficit.

Management strategies used after 4 to 6 months include a bilateral myringotomy with tympanostomy tubes to manage bilateral otitis media with effusion that has lasted a total of 4 to 6 months in an otherwise healthy child aged 1 to 3 years who has a bilateral hearing deficit.

NURSING INTERVENTIONS